Tau Brain Imaging in Typical and Atypical Alzheimer's Disease (AD) (TEPTAU)
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms TEPTAU
- 31 Aug 2018 Biomarkers information updated
- 20 Feb 2017 Status changed from not yet recruiting to recruiting.
- 23 Jan 2017 Planned initiation date changed from 1 Feb 2017 to 23 Jan 2017.